Some European countries have temporarily stopped vaccination after AstraZeneca vaccination due to adverse reactions. However, he explained that there is no association with the vaccine yet, and it is a preventive investigation measure.
This is Jung Hye-kyung.
<기자>
Health authorities in Denmark, Norway, Italy and Iceland say they are suspending the use of the AstraZeneca vaccine.
On the 11th local time, Reuters reported that a 60-year-old woman in Denmark also developed a blood clot and died after getting the AstraZeneca vaccine.
Danish authorities believe the woman has received the same manufacturing unit vaccine as a woman who previously died of similar symptoms in Austria.
The manufacturing unit vaccine has so far been supplied to 17 European countries.
However, countries that have decided to discontinue use said it could not be concluded on the link between the vaccine and blood clots as a prophylactic measure for investigation.
The European Medicines Agency reaffirmed its confidence in the vaccine, saying, “The efficacy of vaccination is far higher than the risk” in a statement to the member countries’ subsequent discontinuation of the vaccine.
Other countries, such as the UK, also emphasized that no adverse reactions were found, and said they would not change the existing recommendations.
[도미니크 라아브/영국 외무장관 : 아스트라제네카에 대해선 상황을 파악하고 있습니다. 영국은 모든 테스트를 거쳤고 백신 안전성에 대해 매우 자신이 있습니다.]
Meanwhile, the European Union has officially approved the use of a vaccine developed by the US pharmaceutical company Johnson & Johnson.
This has increased the number of vaccines available within the European Union to four.